Mackay Shields LLC Edwards Lifesciences Corp Transaction History

Mackay Shields LLC

$565 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$86.5 - $128.27 $7.74 Million - $11.5 Million	-89,508 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $359,816 - $452,911	-3,529 Reduced 3.79%	89,508 $10.5 Million
Q4 2021 Feb 04, 2022	SELL	$106.37 - $130.68 $193,806 - $238,098	-1,822 Reduced 1.92%	93,037 $12.1 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $283,002 - $337,562	-2,750 Reduced 2.82%	94,859 $10.7 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $486,523 - $607,922	-5,803 Reduced 5.61%	97,609 $10.1 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $53,109 - $61,202	-675 Reduced 0.65%	103,412 $8.65 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $600,547 - $764,233	-8,377 Reduced 7.45%	104,087 $9.5 Million
Q3 2020 Nov 04, 2020	BUY	$67.19 - $87.44 $223,541 - $290,912	3,327 Added 3.05%	112,464 $8.98 Million
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $4.36 Million - $5.83 Million	75,709 Added 226.48%	109,137 $7.54 Million
Q1 2020 May 08, 2020	BUY	$52.41 - $81.0 $12,578 - $19,440	240 Added 0.72%	33,428 $6.31 Million
Q4 2019 Feb 11, 2020	SELL	$71.7 - $82.09 $718,792 - $822,952	-10,025 Reduced 23.2%	33,188 $7.74 Million
Q3 2019 Nov 01, 2019	BUY	$61.55 - $75.43 $450,299 - $551,845	7,316 Added 20.38%	43,213 $9.5 Million
Q2 2019 Aug 13, 2019	SELL	$55.74 - $64.41 $619,605 - $715,981	-11,116 Reduced 23.64%	35,897 $6.63 Million
Q1 2019 May 13, 2019	SELL	$47.89 - $64.05 $287,675 - $384,748	-6,007 Reduced 11.33%	47,013 $9 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $910,749 - $1.12 Million	19,624 Added 58.76%	53,020 $8.12 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $32,812 - $41,665	-718 Reduced 2.1%	33,396 $5.81 Million
Q2 2018 Aug 06, 2018	SELL	$42.45 - $51.3 $64,014 - $77,360	-1,508 Reduced 4.23%	34,114 $4.97 Million
Q1 2018 May 03, 2018	BUY	$37.19 - $47.45 $1.32 Million - $1.69 Million	35,622 New	35,622 $4.97 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Account